Author

S. Hopple

Observed names: S L Hopple, S. L. HOPPLE, Sara Hopple, Sara L. Hopple

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Merck Canada Inc. (Canada)

OpenAlex ID: A5077720552

L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor

1989 · J. Gillard, A. W. Ford-Hutchinson, et al. · Canadian Journal of Physiology and Pharmacology · 324

L-656,224 (7-chloro-2-[(4-methoxyphenyl)methyl]-3-methyl-5-propyl-4-benzofuranol): a novel, selective, orally active 5-lipoxygenase inhibitor

1987 · P. Belanger, A. Maycock, et al. · Canadian Journal of Physiology and Pharmacology · 29

Effects of protein kinase C activation on human platelet cyclic AMP metabolism

1987 · Mark Bushfield, Sara L. Hopple, et al. · FEBS Letters · 10

Pharmacology of the dual inhibitor of cyclooxygenase and 5-lipoxygenase 3-hydroxy-5-trifluoromethyl-N-(2-(2-thienyl)-2-phenyl-ethenyl)-benzo (b)thiophene-2-carboxamide.

1988 · P J Bailey, A L Dallob, et al. · PubMed · 5

Leukotrienes and Asthma

1992 · J. Rokach, M. Barth, et al. · Springer eBooks · 4

Assessment of gastric bleeding in rats: Effects of cyclooxygenase inhibitors and 16,16-dimethyl prostaglandin E2 on gastric bleeding

1987 · R. J. Bonney, S. Glinka, et al. · Inflammation Research · 4

REGULATION OF PLATELET cAMP FORMATION BY PROTEIN KINASE C

1987 · Sara Hopple, Mark Bushfield, et al. · Thrombosis and Haemostasis · 1

ChemInform Abstract: Synthesis and Structure‐Activity Relationships of a Novel Class of 5‐Lipoxygenase Inhibitors. 2‐(Phenylmethyl)‐4‐hydroxy‐3,5‐dialkylbenzofurans: The Development of L‐656,224.

1989 · C. K. LAU, P. C. BELANGER, et al. · ChemInform

Works count: 8

Citation count: 377

H-index: 4

I10-index: 3